Recombinant Bordetella bronchiseptica Membrane protein insertase YidC (yidC)

What is YidC and what is its primary function in Bordetella bronchiseptica?

YidC is an essential bacterial membrane protein that facilitates the insertion and assembly of proteins destined for integration into the inner membrane. In Bordetella bronchiseptica, as in other Gram-negative bacteria, YidC serves as a membrane protein insertase that can function either independently or in concert with the SecY complex to mediate co-translational membrane protein integration . The insertase activity of YidC is primarily located in the C-terminal five transmembrane regions, which are highly conserved across bacterial species .

How is the structure of B. bronchiseptica YidC organized?

Based on structural studies of bacterial YidC proteins, B. bronchiseptica YidC likely consists of six transmembrane (TM) domains with a large periplasmic domain (approximately 35 kDa) located between TM1 and TM2 . The core structure forms a helical bundle arranged like the vertices of a pentagon when viewed from the cytoplasm, with TM helices organized in the order 4-5-3-2-6 (clockwise) . The first transmembrane helix (TM1) lies along the periphery of this core structure as revealed in the crystal structure of Thermotoga maritima YidC . The conserved membrane-integrated core of YidC forms this pentagonal arrangement that creates a hydrophilic groove at the protein-lipid interface, which likely serves as the insertion site for substrate proteins .

What experimental systems are available for expressing recombinant B. bronchiseptica YidC?

For recombinant expression of B. bronchiseptica YidC, researchers typically employ E. coli expression systems using vectors containing inducible promoters such as T7. The standard approach involves:

• Cloning the yidC gene from B. bronchiseptica into an expression vector with a C-terminal or N-terminal affinity tag (such as His-tag)

• Transforming the construct into an E. coli expression strain such as BL21(DE3)

• Growing cultures at 37°C to an appropriate optical density (typically A600 of 0.6)

• Inducing expression with IPTG (typically 1 mM)

• Harvesting cells after 3-4 hours of induction

• Lysing cells using mechanical disruption methods such as sonication or pressure-based systems (e.g., Emulsiflex)

Purification is then performed using affinity chromatography, followed by size exclusion chromatography to obtain pure protein for functional and structural studies.

How do I design an effective in vivo complementation assay to assess B. bronchiseptica YidC function?

An in vivo complementation assay for B. bronchiseptica YidC function can be designed based on the essential nature of YidC in bacterial cells. The methodology involves:

• Constructing a conditional YidC depletion strain in E. coli where the endogenous yidC gene is under control of an inducible promoter

• Transforming this strain with a plasmid expressing B. bronchiseptica YidC

• Shifting growth conditions to deplete endogenous YidC

• Assessing whether B. bronchiseptica YidC can rescue growth

For mutational analysis, key residues can be selected based on evolutionary conservation and structural models. Critical residues like those corresponding to E. coli T362 in TM2 and Y517 in TM6 are excellent candidates for alanine substitution mutagenesis to assess their importance in YidC function . After mutagenesis, expression levels should be confirmed by western blotting to ensure that any functional defects observed are not due to protein instability .

What regions of B. bronchiseptica YidC are most critical for its insertase function?

Based on deletion analyses and structural studies of YidC from other bacteria, the insertase function of B. bronchiseptica YidC is likely concentrated in the C-terminal five transmembrane regions (TM2-TM6) . While up to 90% of the large periplasmic domain between TM1 and TM2 can be deleted without severely affecting cell viability or inner membrane protein biogenesis in E. coli YidC , the C-terminal residues 323-346 of this periplasmic domain (corresponding to a conserved α-helix) are essential for insertase activity .

Additionally, molecular dynamics simulations and mutational studies have identified specific residues within the transmembrane domains that are critical for stability and function. These include residues involved in:

• Polar or charged interactions on the cytoplasmic side of the protein core

• Aromatic residue stacking on the periplasmic side

• Specific interhelical interactions, particularly between TM2 and TM6

How can I assess the interaction between B. bronchiseptica YidC and translating ribosomes?

To assess YidC-ribosome interactions, researchers can employ the following methodology:

• Generate ribosome-nascent chain complexes (RNCs) by:

  • Constructing templates for in vitro transcription/translation containing the first transmembrane segment of a known YidC substrate

  • Adding a translation arrest sequence to stabilize the ribosome-nascent chain complex

  • Performing in vitro translation in the presence of purified B. bronchiseptica YidC in detergent micelles

• Analyze the complexes using:

  • Sucrose gradient centrifugation to isolate RNC-YidC complexes

  • Cryo-electron microscopy (cryo-EM) to visualize the structural arrangement

  • Chemical cross-linking followed by mass spectrometry to identify specific contact points

Cryo-EM analysis has revealed that YidC binds to the ribosomal tunnel exit with the nascent transmembrane helix positioned near YidC's TM3 . This technique allows visualization of how a single copy of YidC interacts with the ribosome and identifies the site for membrane protein insertion at the YidC protein-lipid interface .

How do I design experiments to distinguish between Sec-dependent and Sec-independent YidC-mediated insertion pathways using B. bronchiseptica YidC?

To investigate the dual functionality of B. bronchiseptica YidC in Sec-dependent and Sec-independent insertion pathways, researchers can implement the following experimental approach:

• Substrate selection:

  • Choose known YidC-only substrates (e.g., Pf3 coat protein, M13 procoat)

  • Select SecYEG-YidC dependent substrates (e.g., FtsQ, CyoA)

  • Include B. bronchiseptica-specific inner membrane proteins

• In vitro reconstitution system:

  • Purify B. bronchiseptica YidC and reconstitute into proteoliposomes

  • Prepare separate proteoliposomes containing SecYEG complex

  • Create combined proteoliposomes with both SecYEG and YidC

  • Use fluorescently labeled substrate proteins to track insertion

• Analysis of insertion efficiency:

  • Protease protection assays to assess topology

  • Sucrose flotation assays to confirm membrane integration

  • Fluorescence-based real-time insertion assays

• Crosslinking analysis:

  • Incorporate photoactivatable or chemical crosslinkers at specific positions in substrate proteins

  • Identify crosslinked adducts by mass spectrometry to map interaction sites

  • Compare crosslinking patterns between YidC-only and SecYEG+YidC systems

These experiments would provide mechanistic insights into how B. bronchiseptica YidC functions independently and in concert with the Sec machinery, potentially revealing species-specific adaptations in membrane protein biogenesis pathways.

What are the critical differences between YidC homologues across bacterial species, and how might these affect functional studies of B. bronchiseptica YidC?

The evolutionary conservation and divergence patterns among YidC homologues can significantly impact experimental design and interpretation when studying B. bronchiseptica YidC:

When designing functional complementation studies, researchers should consider:

• The conservation level of specific residues between E. coli and B. bronchiseptica YidC, especially in:

  • The hydrophilic groove formed by TM3 and TM5, which is implicated in substrate binding

  • The cytoplasmic ribosome-binding regions

  • The C-terminal α-helix of the periplasmic domain that is essential for function

• Specific adaptations that may reflect the pathogenic lifestyle of B. bronchiseptica, potentially affecting:

  • Substrate specificity for virulence factors

  • Membrane protein insertion under stress conditions encountered during infection

Cross-species complementation assays can reveal functionally interchangeable regions versus species-specific domains that have evolved distinct functions .

How can molecular dynamics simulations be used to predict critical functional residues in B. bronchiseptica YidC for experimental validation?

Molecular dynamics (MD) simulations provide powerful tools for predicting functionally important residues in B. bronchiseptica YidC prior to experimental testing:

• Model generation and refinement:

  • Build a homology model of B. bronchiseptica YidC based on crystal structures of homologues

  • Embed the model in a lipid bilayer mimicking the bacterial inner membrane composition

  • Perform equilibration simulations (typically 100-500 ns) to stabilize the system

• Analysis of inter-residue interactions:

  • Calculate interaction energies between residues to identify stabilizing contacts

  • Focus on hydrophobic residues on the exterior that mediate lipid interactions

  • Identify polar/charged residues that form networks within the protein core

  • Pay special attention to aromatic residues on the periplasmic side that participate in stacking interactions

• Substrate channel analysis:

  • Simulate water penetration into the hydrophilic groove formed between TM segments

  • Track the dynamics of the groove dimensions to identify potential gating mechanisms

  • Use steered MD to model nascent chain insertion pathways

• Experimental validation strategy:

  • Select 10-15 residues with the highest predicted interaction energies

  • Generate alanine substitution mutants (or more conservative substitutions for critical residues)

  • Test using in vivo complementation assays described above

  • Verify protein stability using western blotting

  • For functional mutants, perform detailed biophysical characterization

Previous MD simulations with E. coli YidC identified critical residues T362 in TM2 and Y517 in TM6, which completely inactivated YidC when mutated to alanine despite stable expression . Similar approaches can identify the corresponding crucial residues in B. bronchiseptica YidC.

What methods can be used to solve the structure of B. bronchiseptica YidC, and what special considerations apply?

Multiple complementary approaches can be employed to determine the structure of B. bronchiseptica YidC:

• X-ray crystallography:

  • Focus on crystallizing the periplasmic domain separately, as demonstrated for E. coli YidC

  • Consider limited proteolysis to identify stable fragments

  • Engineer surface mutations to enhance crystallization (as in the E. coli YidC periplasmic domain where mutations E228A, K229A, E231A, K232A, and K234A improved crystal quality)

  • Use lipidic cubic phase crystallization for the full-length protein

• Cryo-electron microscopy:

  • Prepare YidC in detergent micelles or nanodiscs

  • Consider ribosome-bound complexes to enhance particle size and aid in alignment

  • Use substrate-engaged YidC to capture functional states

• Integrative structural biology approaches:

  • Employ evolutionary covariation analysis to predict residue contacts as successfully used for E. coli YidC

  • Validate models using lipid versus protein exposure prediction methods

  • Combine with molecular dynamics simulations to refine structural models

  • Incorporate crosslinking data to constrain model building

Special considerations for B. bronchiseptica YidC include optimizing detergent selection for extraction from membranes, addressing potential flexibility in the periplasmic domain, and capturing functionally relevant conformational states during the insertion process.

How can I investigate the substrate specificity of B. bronchiseptica YidC in the context of pathogenesis?

To investigate the substrate specificity of B. bronchiseptica YidC with particular focus on virulence factors:

• Substrate identification:

  • Perform comparative proteomics of membrane proteins in YidC-depleted versus wild-type B. bronchiseptica

  • Use SILAC (stable isotope labeling with amino acids in cell culture) to quantify changes in protein abundance

  • Conduct in vivo crosslinking followed by immunoprecipitation and mass spectrometry to identify direct YidC interactors

  • Focus on virulence factors that require membrane insertion for function

• Validation of YidC dependence:

  • Construct conditional YidC depletion strains in B. bronchiseptica

  • Assess localization of candidate substrates using fractionation and western blotting

  • Employ in vitro translation/insertion assays with purified components

  • Perform site-specific crosslinking to map YidC-substrate contact sites

• Pathogenesis-relevant functional analysis:

  • Evaluate the impact of YidC depletion on B. bronchiseptica adherence to respiratory epithelial cells

  • Assess secretion of virulence factors that require proper membrane protein insertion

  • Examine biofilm formation capacity under YidC limitation

  • Test virulence in appropriate animal models with regulated YidC expression

This methodology would reveal whether B. bronchiseptica YidC has evolved specific adaptations for inserting pathogenesis-related membrane proteins and could identify novel targets for antimicrobial development.

How can I establish a cell-free translation system to study B. bronchiseptica YidC-mediated membrane protein insertion?

A reconstituted cell-free translation system provides precise control over the components involved in YidC-mediated insertion:

• Cell-free extract preparation:

  • Prepare S30 extract from B. bronchiseptica or E. coli

  • Deplete endogenous YidC using immunoaffinity methods

  • Supplement with T7 RNA polymerase for coupled transcription-translation

• Membrane mimetics:

  • Prepare proteoliposomes containing purified B. bronchiseptica YidC

  • Control lipid composition to mimic B. bronchiseptica inner membrane

  • Use nanodiscs as an alternative membrane system for better accessibility

• Translation reaction setup:

  • Use plasmids encoding YidC substrates under T7 promoter control

  • Include fluorescently labeled lysine-tRNA or cysteine-reactive fluorophores for detection

  • Add purified B. bronchiseptica YidC at varying concentrations

  • Compare wild-type YidC with specific point mutants

• Analysis methods:

  • Monitor insertion using protease protection assays

  • Employ sucrose gradient centrifugation to isolate membrane-integrated products

  • Use FRET-based assays to track real-time insertion kinetics

  • Analyze topology using substituted cysteine accessibility method (SCAM)

This system allows systematic variation of components to dissect the minimal requirements for B. bronchiseptica YidC-mediated insertion and can reveal substrate-specific insertion mechanisms.

What approaches can be used to study the interaction between B. bronchiseptica YidC and the Sec translocon complex?

To investigate the YidC-SecYEG interaction in B. bronchiseptica:

• Biochemical interaction analysis:

  • Co-purification studies using affinity-tagged YidC or SecY

  • Pull-down assays to identify stable complexes

  • Blue native PAGE to visualize native complexes

  • Surface plasmon resonance to measure binding kinetics

  • Focus on the region corresponding to residues 215-265 in E. coli YidC, shown to be sufficient for SecF binding

• Structural characterization:

  • Crosslinking-MS to map interaction interfaces

  • Negative stain EM of purified complexes

  • Cryo-EM to visualize YidC-SecYEG-ribosome assemblies

  • Construct fusion proteins to stabilize transient interactions

• Functional analysis:

  • Reconstitute purified YidC and SecYEG into proteoliposomes

  • Compare insertion efficiency of model substrates requiring both YidC and SecYEG

  • Mutate predicted interface residues and assess impact on complex formation

  • Deploy in vivo assays measuring membrane protein biogenesis of SecYEG-YidC dependent substrates

• Real-time visualization:

  • Utilize fluorescently labeled YidC and SecY to track complex formation using single-molecule techniques

  • Employ FRET to monitor conformational changes during substrate handling

  • Develop split fluorescent protein complementation assays to visualize interaction in living cells

These approaches would provide insights into whether the B. bronchiseptica YidC-Sec interaction has specific adaptations compared to model organisms like E. coli.